LBP inhibitory peptide reduces endotoxin-induced macrophage activation and mortality

Inflammation Research

Volumn 54, Issue 11, 2005, Pages 451-457

  Wu, X ^a   Qian, G ^a   Zhao, Y ^b   Xu, D ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Lipopolysaccharide; Lipopolysaccharide binding protein; Nuclear factor kappa B

Indexed keywords

ALANINE AMINOTRANSFERASE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPOLYSACCHARIDE BINDING PROTEIN INHIBITORY PEPTIDE P12; NITRIC OXIDE; PROTEIN INHIBITOR; PROTEIN SUBUNIT; SYNAPTOTAGMIN; TRYPTOPHANYLLYSYLVALYLARGINYLLYSYLSERYLPHENYLALANYLPHENYLALANYLLYSYLLEUCYL GLUTAMINYLGLYCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL STIMULATION; CELL STRAIN U937; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FISHER EXACT TEST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE STRAIN; NONHUMAN; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SHOCK; STATISTICAL SIGNIFICANCE; TAIL; VEIN; WESTERN BLOTTING;

ACUTE-PHASE PROTEINS; ALANINE TRANSAMINASE; ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DEATH; ENDOTOXEMIA; ENDOTOXINS; FLOW CYTOMETRY; HEPATITIS, TOXIC; HUMANS; INDICATORS AND REAGENTS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; NITRIC OXIDE; PC12 CELLS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 28044446973     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-1378-1     Document Type: Article

References (31)

1. Rietschel ET, Brade H, Holst O, Brade L, Muller LS, Mamat U et al. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216: 39-81.
2. Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11: 19-22.
3. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide binding acute phase reactant from rabbit serum. J Exp Med 1986; 164: 785-93.
4. Yu B, Wright SD. Catalytic properties of lipopolysaccharide (LPS) binding protein (LBP): Transfer of LPS to soluble CD14. J Biol Chem 1996; 271: 4100-5.
5. Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11: 13-8.
6. May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol Today 1998; 19: 80-8.
7. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-7.
8. Brightbill HD, Modlin RL. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology 2000; 101: 1-10.
9. Medzhitov R, Janeway C. Innate immunity. N Engl J Med 2000; 343: 338-14.
10. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-31.
11. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol 1992; 149: 200-6.
12. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025-35.
13. Xu DB, Qian GS, Hou YF, Zhao XL, Chen wz, Li SP. Analysis of LBP functional site. Med J Clin PLA 2004; 29: 85.
14. Xu DB, Qian GS, Hou YF, Zhao XL, Chen wz, Li SP. Study on anti-inflammatory site of LBP by phage display. Acta Academiae Medicine Militaris Tertiae 2004; 26: 573-5.
15. Moreno-Altamirano MM, Sanchez-Garcia FJ, Munoz ML. Non Fc receptor-mediated infection of human macrophages by dengue virus serotype 2. J Gen Virol 2002; 83: 1123-30.
16. Minta JO, Pambrun L. In vitro induction of cytologic and functional differentiation of the immature human monocyte-like cell line U-937 with phorbol myristate acetate. Am J Pathol 1985; 119: 111-26.
17. Lin SM, Frevert CW, Kajikawa O, Wurfel MM, Ballman K, Mongovin S et al. Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages. Am J Respir Cell Mol Biol 2004; 31: 162-70.
18. Nakamura K, Yokohama S, Yoneda M, Okamoto S, Tamaki Y, Ito T et al. High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice. J Gastroenterol 2004; 39: 346-54.
19. Haddad JJ, Safieh-Garabedian B, Saade NE, Lauterbach R. Inhibition of glutathione-related enzymes augments LPS-mediated cytokine biosynthesis: involvement of an IκB/NF-κB-sensitive pathway in the alveolar epithelium. Int Immunopharmacol 2002; 2: 1567-83.
20. Carter AB, Monick MM, Hunninghake GW. Lipopolysaccharide-induced NF-kappa B activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 1998; 18: 384-91.
21. Richlin VA, Arevalo JM, Zack JA, Cole SW. Stress-induced enhancement of NF-kappa B DNA-binding in the peripheral blood leukocyte pool: effects of lymphocyte redistribution. Brain Behav Immun 2004; 18: 231-7.
22. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 1995; 41: 904-7.
23. Tasaka S, Ishizaka A, Yamada W, Shimizu M, Koh H,Hasegawa N et al. Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am J Respir Cell Mol Biol 2003; 29: 252-8.
24. Taylor AH, Heavner G, Nedelma M, Sherris D, Brunt E, Knight D et al. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J Biol Chem 1995; 270: 17934-8.
25. Sugita N, Kimura A, Matsuki T, Yamamoto T, Yoshie H, Hara K et al. Activation of transcription factors and IL-8 expression in neutrophils stimulated with lipopolysaccharide from Porphyromonas gingivalis. Inflammation 1998; 22: 253-67.
26. Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002; 323: 59-72.
27. Gallay P, Heumann D, Le-Roy D, Barras C, Glauser MP. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci USA 1994;91:7922-6.
28. Le-Roy D, Di-Padova F, Tees R, Lengacher S, Landmann R, Glauser MP et al. Monoclonal Antibodies to Murine Lipopolysaccharide (LPS)-Binding Protein (LBP) Protect Mice from Lethal Endotoxemia by Blocking Either the Binding of LPS to LBP or the Presentation of LPS/LBP Complexes to CD14. J Immunol 1999; 162: 7454-60.
29. Knapp S, de Vos AF, Florquin S, Golenbock DT, van der Poll T. Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect Immun 2003; 71: 6747-53.
30. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800-8.
31. Le-Roy D, Di-Padova F, Adachi Y, Glauser MP, Calandra T, Heumann D. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol 2001; 167: 2759-65.